Clinical Trial Update: Study of Efficacy and Safety of Eltrombopag in Lower-risk MDS Patients With Platelet Transfusion Dependence [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of eltrombopag for lower-risk myelodysplastic syndromes in patients with platelet transfusion depend…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Myelodysplastic Syndromes | Phase 2 | Status: ACTIVE_NOT_RECRUITING